{
  "url": "https://openlegislation.uk/chemicals-health-and-safety-and-genetically-modified-organisms-contained-use-amendment-etc-eu-exit-regulations-2019/schedule-2/paragraph-227",
  "json_url": "https://openlegislation.uk/chemicals-health-and-safety-and-genetically-modified-organisms-contained-use-amendment-etc-eu-exit-regulations-2019/schedule-2/paragraph-227.json",
  "legislation": "uksi/2019/720",
  "legislation_title": "The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/chemicals-health-and-safety-and-genetically-modified-organisms-contained-use-amendment-etc-eu-exit-regulations-2019",
  "path": "schedule/2/paragraph/227",
  "kind": "paragraph",
  "number": "227",
  "heading": null,
  "text": "(1) Article 15 is amended as follows.\n(2) For “Annex I to that Regulation” substitute “ the Simplified Active Substance List ”.\n(3) In point (a)—\n(a) for “the person placing the product on the market” insert “ the product was placed on the market before IP completion day and the person placing the product on the market ”;\n(b) after the words “by the Commission” insert “ before IP completion day or the competent authority after IP completion day ”.\n(4) After point (a) insert—\n“(aa) the product was placed on the market after IP completion day and the person placing the product on the market has relied on guidance published by, or written advice received from, the competent authority after IP completion day, where that guidance or advice gave objectively justified reasons to believe that the product was excluded from the scope of Regulation (EU) No 528/2012, or that the relevant product-type was one for which the active substance had been notified and where that guidance or advice is subsequently reviewed in a decision issued pursuant to Article 3(3) of Regulation (EU) No 528/2012 or in new, authoritative guidance published by the Competent Authority;”.\n(5) In point (b), at the end insert “ and the person placing the product on the market has complied with the time limits provided for by Regulation (EU) No 528/2012 ”.\n(6) Omit point (c).",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. 2 para. 227(3) substituted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 2 para. 70(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Sch. 2 para. 227(4) substituted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 2 para. 70(a)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Sch. 2 para. 227(4) inserted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 2 para. 70(b)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 2 para. 227 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2019/720/schedule/2/paragraph/227",
    "retrieved_at": "2026-10-28T22:42:46.757889+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}